The state of adolescent girls' reproductive health


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. The study aimed to characterize the normative AMH levels amongst adolescent girls in Armenia, assess reproductive health, and take preventive measures for infertility. Materials and methods. The study included 700 10-18-year-old adolescent girls randomly selected from different regions of Armenia, including Yerevan. Clinical evaluation included serum levels of AMH, FSH, LH, TSH, anti-TPO, as well as thyroid gland and pelvic ultrasound examination. Results. The individual AMH level in 10-15-year-old adolescent girls ranged from 2.0 to 4.0 ng/ml and among 16-18-year-old adolescent girls from 1.5-4.0 ng/ml. The normal ovarian reserve has the following characteristics: AMH level not less than 2.0 mg/ml, FSH level not more than 10 m U/ml, AFC at least 5 in each ovary, and ovarian volume, not less than 5cm3. A total of 469 (67%) adolescents had a normal AMH level and normal ovarian reserve. 231 (33%) adolescent girls were at high risk for diminished ovarian reserve, menstrual disorders, infertility, and reproductive losses. Conclusion. The study established the normative values for serum AMH and evaluated the normal ovarian reserve of Armenian adolescent girls. Knowledge of low ovarian reserve and its prognostic significance allows identifying risk groups of adolescent girls at an early stage. This enables the determination of reproductive behavior and prevention of reproductive losses and infertility in the reproductive age.

Full Text

Restricted Access

About the authors

Hasmik H. Bareghamyan

Mkhitar Heratsi Yerevan State Medical University; Beglaryan Medical Center

Email: hasmik3185@gmail.com
MD, Obstetrician and Gynecologist, Beglaryan MC; Lecturer at the Department of Obstetrics and Gynecology №1, Mkhitar Heratsi Yerevan State Medical University. Yerevan, Armenia

Aharon A. Barseghyan

Wigmore Clinic

Email: aharonbarseghyan@gmai.com
Ph.D. Yerevan, Armenia

Gagik A. Beglaryan

Mkhitar Heratsi Yerevan State Medical University; Beglaryan Medical Center

MD, Dr. Med. Sci., Professor, Academician of UN Elite International academy; Head of the Department of Obstetrics and Gynecology No. 1, Mkhitar Heratsi Yerevan State Medical University; Director of the Beglaryan MC Yerevan, Armenia

References

  1. Gleicher N., Weghofer A., Barad D.H. Anti-Mullerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil. Steril. 2010; 94(7): 2824-7. https://dx.doi.org/10.1016/j.fertnstert.2010.04.067.
  2. Dewailly D., Andersen C.Y., Balen A., Broekmans F., Dilaver N., Fanchin R. et al. The physiology and clinical utility of anti- Mullerian hormone in women. Hum. Reprod. Update. 2014; 20(3): 370-85. https://dx.doi.org/10.1093/humupd/dmt062.
  3. Pawelczak M., Kenigsberg L., Milla S., Liu Y.H., Shah B. Elevated serum anti-Mullerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features. J. Pediatr. Endocrinol. Metab. 2012; 25(9-10): 983-9. https://dx.doi.org/10.1515/jpem2012-0013.
  4. Kaur M., Arora M. Diminished ovarian reserve, cause, assessment and management. Int. J. Infertil. Fetal Med. 2013; 4(2): 45-55. https://dx.doi.org/10.5005/jp-journals-1016-1060.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies